Pfizer signs license agreement allowing global access to experimental COVID-19 antiviral pill

WRCB Chattanooga

Nov 16, 2021

Pfizer has yet to submit the pill for authorization by the US Food and Drug Administration but said it would do so before the end of the month. |!| Chattanooga